share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)

Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Matrix Capital Management Company LP(14.73%),David E. Goel(14.73%)

美股SEC公告 ·  2024/11/13 14:08
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息